Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals
about
Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugatesInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyPhase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.Infectious diseases associated with complement deficiencies.Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophilsProperdin deficiency and meningococcal disease--identifying those most at risk.The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.Update on meningococcal disease with emphasis on pathogenesis and clinical managementHuman opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorBProtection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes.Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.Meningococcal disease and the complement system.Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant ratsThe immunopathogenesis of meningococcal disease.Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burstComparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccineBactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraoseStudy of the role of the htrB gene in Salmonella typhimurium virulence.Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae.Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping.Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeaeCurrent status of meningococcal group B vaccine candidates: capsular or noncapsular?Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.Cross-reacting serum opsonins in patients with meningococcal disease.Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection.Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Characterization of strains of Neisseria meningitidis recovered from complement-sufficient and complement-deficient patients in the Western Cape Province, South Africa.Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C.Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.Genome-based approaches to vaccine development.Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidisRelationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes.
P2860
Q28333417-8C12D9E4-ED6E-4485-87FE-75DBEFEA1F88Q28972389-29F30092-68F8-454F-B8F0-FFD0028905F1Q30227840-EE5A5E9E-E564-41CB-8FEF-9A668B2E78D1Q30450183-8956D309-C734-414C-84DE-C627835528D7Q33751449-974352DE-E008-4A68-B45F-2C7FDABF3704Q33762493-CA567E1C-6610-4532-9F4A-CAAC258C194AQ33769638-AA971CDF-44EE-4E5F-AD27-BCDF3942BB08Q33812435-309E17D8-33C2-4208-B939-069955BA1EF8Q33867635-24433C92-A3F2-45D0-8C4A-34E3A55FE02FQ33946852-83053FBF-ED79-4FC6-BDFE-7DA3476ABF7BQ34002783-528AA165-243E-44D0-998D-BDB1BB68F3C7Q34007332-2EE21000-0166-4DF5-AAED-691DBF9D9A63Q34131301-9CF1E4F5-1FCA-4879-88BE-6E30A5B6AE4AQ34376170-8ADFEFD5-F555-42B3-A58A-4691D8B69CFFQ34521522-F5D57C0C-A0D6-419C-AA90-F5369932580DQ34602010-4BB08CA4-42A1-4F16-A364-360D2529C6DCQ35144175-61F8EA9D-4FB7-44FB-AE68-110A5CAE5B45Q35379174-2EBE36FE-1003-4788-9BE9-3E6399DFD4CBQ35437531-27C82622-5159-40CF-B9C5-EC06C40A3529Q35544353-422F8D5B-D924-4272-8608-2A7067AECCDAQ35557535-2D059CAD-1D57-40F6-BD45-A2DA3A06F9E9Q35558821-74DD3369-B1F3-4B85-AF19-32F121681913Q35779576-AF21A3FA-5471-4F49-B29E-057E3A0B6FD6Q35946901-B98124ED-5ED9-436E-BE3B-B9A7990C0779Q36095135-FE169C50-04ED-46E7-90A3-C214AB02354FQ36504254-4B54ECF3-BD39-4B33-B74B-C789F49BC6DFQ36633889-4029CE60-47C7-44E8-AA5D-D5AD521D2561Q36642138-61FF596F-87CE-418D-A200-0133B11E397DQ36672529-0C555B50-3C7D-4DC0-A349-85D7D7E448D8Q36947524-D587C733-45C7-49C8-99B4-34741DF37051Q36997996-C49F294E-D288-4A0A-B0F6-5424BFFBE73EQ37058833-437B6698-4925-44D8-AD72-B6DB6247D6F8Q37091321-522DCE28-393A-4572-B1FB-88B4F9CE3140Q37215825-9EB9A8D0-09F7-45B7-8F70-AE7CB442E077Q37362174-059481BD-112D-48E8-93A0-DDCB988DE267Q37672379-202F1539-38AF-4992-B7B4-22A856C2D79AQ38342684-0D51A975-51F8-400E-8A46-8DE02B62DE0AQ39507497-2A16A536-25A1-4CDF-81D5-F9225EC13142Q39625556-E86B57CC-43AE-446F-966D-483825459497Q39913062-8BDB2E02-1D65-4F91-934C-7B65BED8C562
P2860
Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Killing of Neisseria meningiti ...... mplement-deficient individuals
@ast
Killing of Neisseria meningiti ...... mplement-deficient individuals
@en
Killing of Neisseria meningiti ...... mplement-deficient individuals
@nl
type
label
Killing of Neisseria meningiti ...... mplement-deficient individuals
@ast
Killing of Neisseria meningiti ...... mplement-deficient individuals
@en
Killing of Neisseria meningiti ...... mplement-deficient individuals
@nl
prefLabel
Killing of Neisseria meningiti ...... mplement-deficient individuals
@ast
Killing of Neisseria meningiti ...... mplement-deficient individuals
@en
Killing of Neisseria meningiti ...... mplement-deficient individuals
@nl
P2093
P356
P1476
Killing of Neisseria meningiti ...... mplement-deficient individuals
@en
P2093
H M Berberich
P J Rosenthal
P304
P356
10.1093/INFDIS/155.6.1266
P407
P577
1987-06-01T00:00:00Z